| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |
| 04/28/2004 | EP1412380A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis |
| 04/28/2004 | EP1411975A1 Methylation of histone h4 at arginine 3 |
| 04/28/2004 | EP1286684B1 use of cxcr4 antagonists for treating autoimmune diseases and cancer |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492766A Prevention of diabetes by administration of GnRH antagonists |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/27/2004 | US6727366 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors |
| 04/27/2004 | US6727223 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
| 04/22/2004 | WO2004033500A1 Peptides modulating caspase activation |
| 04/22/2004 | WO2004033489A1 Template-fixed peptidomimetics with antimicrobial activity |
| 04/22/2004 | WO2004033482A2 Phenolic binding peptides |
| 04/22/2004 | WO2004033479A2 Retroyclins: antiviral and antimicrobial peptides |
| 04/22/2004 | WO2004022657A8 Increasing of the resorption of substances via skin and mucous membranes |
| 04/22/2004 | WO2003105907A3 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 04/22/2004 | WO2003051272A9 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 04/22/2004 | WO2003046565A3 Ig lambda biopolymer markers predictive of alzheimers disease |
| 04/22/2004 | WO2003040176A3 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 04/22/2004 | WO2003029428A8 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/22/2004 | US20040077843 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077827 Process for the synthesis of a peptide having a trp residue |
| 04/22/2004 | US20040077549 Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| 04/22/2004 | US20040077547 Preventing catalytic conversion of factors X, VII AND IX to Xa, VIIa and IXa respectively |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077037 Regiospecific modification of peptides and proteins with probes and reporter molecules using peptidases in combination with a non-amino acid- like or non-peptide-like substrate mimetic |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076634 An envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 04/22/2004 | CA2502304A1 Phenolic binding peptides |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application |
| 04/21/2004 | EP1410801A1 Method for promoting hematopoietic cell proliferation and differentiation |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409521A2 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 04/21/2004 | EP1409519A1 Lipid-peptide conjugates for treatment of cancer |
| 04/21/2004 | EP1409518A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409482A2 Dye-sulfenates for dual phototherapy |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP0989858B1 Cd28/ctla-4 inhibiting peptidomimetics and pharmaceutical compositions thereof |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1490357A Structural body containing polyhydroxy chain alkyl ester |
| 04/21/2004 | CN1490330A Production of acetooxdralpeptide |
| 04/21/2004 | CN1490329A Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 04/21/2004 | CN1490328A Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723697 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723694 Short peptides which selectively modulate intracellular signalling |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | CA2031486C Synergistins preparation process |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031773A1 Fret protease assays for clostridial toxins |
| 04/15/2004 | WO2004031768A2 Method for screening modulators of mitochondrial functioning |
| 04/15/2004 | WO2004031722A2 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 04/15/2004 | WO2004031381A1 Peptide capable of binding to nanographite structures |
| 04/15/2004 | WO2004031374A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 04/15/2004 | WO2004031221A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031220A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031219A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031218A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031217A1 Vaccines of enhanced immunogenicity, and methods for preparing such vaccines |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004030687A1 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 04/15/2004 | WO2004030650A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 04/15/2004 | WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/15/2004 | WO2004002509A3 Use of casein peptides for treating hypertension |
| 04/15/2004 | WO2003089457B1 Peptide inhibitors of protein kinase c ϝ for pain management |
| 04/15/2004 | WO2003068807A3 Echinocandin cyclic peptide derivatives |
| 04/15/2004 | WO2003040094A9 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein |
| 04/15/2004 | WO2003030834A3 Cyclosporin analogs for the treatment of lung diseases |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2001019852A8 Methods of peptide preparation |
| 04/15/2004 | US20040072992 Novel peptide capable of specifically acting on biological membrane |
| 04/15/2004 | US20040072990 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072743 Pharmaceutical composition of modified pna molecules |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072737 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents |
| 04/15/2004 | US20040072736 First cyclic group, which contains a cysteine group, is formed by an amide bonding of the N-terminal amino acid with the second carboxylate group of a diacid amino acid, and a second cyclic group with amide bonding of alpha-carboxylate |
| 04/15/2004 | US20040072341 Bioactive oligopeptides |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072301 Comprises antiproliferative peptides and/or polypeptides for treating tumors |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |